Given that the non-coding genome has been suggested to contribute to the regulation of RGS protein in oral squamous cell carcinoma [22], cervical cancer [23], ovarian cancer [24] and lung cancer [25]. This evidence concerns the gene PITX2 and ovarian cancer.